Histopathologic Findings in the Heart Associated With Telemetry Instrumentation in Beagle Dogs.
Rebecca Kohnken1, Amanda Wilsey1, Brandan Bird1
1AbbVie, North Chicago, Illinois, USA.
Toxicologic Pathology
|August 19, 2025
Summary
Telemetry instrumentation in dogs for cardiovascular safety studies can cause cardiac pathology. Understanding these changes is crucial for accurately assessing drug toxicity in repurposed animals used in toxicology studies.
Area of Science:
- Veterinary Pathology
- Cardiovascular Toxicology
- Drug Development Safety Assessment
Background:
- Conscious telemetry-instrumented dogs are vital for collecting cardiovascular data (ECG, heart rate, blood pressure, contractility) during early drug development.
- Repurposing dogs from safety assessments into toxicology studies is a strategy to refine animal use, especially after device failure.
- Telemetry instrumentation involves surgical implantation, with potential for variability in catheter placement leading to cardiac pathology.
Purpose of the Study:
- To describe the spectrum of cardiac findings in telemetry-instrumented dogs.
- To inform pathologists about instrumentation-related cardiac changes for accurate toxicologic assessment.
- To provide recommendations for the ethical and effective reuse of these animals in exploratory toxicology.
Main Methods:
- Histologic examination of cardiac tissues from 12 male beagle dogs with telemetry implants.
- Analysis of cardiac findings in relation to implant duration (7-37 months).
- Review of pathological changes associated with left ventricular apex catheter placement.
Main Results:
- Telemetry instrumentation is associated with a range of cardiac pathologies, varying with catheter placement and duration.
- Specific histologic changes related to the surgical procedure and device presence were observed.
- The findings highlight the need for pathologists to differentiate instrumentation-induced changes from drug-related effects.
Conclusions:
- Pathologists must be aware of cardiac alterations caused by telemetry instrumentation to avoid misinterpreting them as adverse drug effects.
- Understanding the spectrum of these histologic changes is essential for the responsible reuse of instrumented dogs in toxicology studies.
- Recommendations are provided for the appropriate use and assessment of these animals in drug development.


